MEDiCALJOURNL 1473 the malignant cases multiple metastases were verified at the time of surgery. Homovanillic acid determination was by a modified fluorometric assay (Sato, 1965) . As shown in the , 1965, 2, 1473-1474 Natulan (N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride) (procarbazine) is a benzyl-methyl hydrazine derivative with cytotoxic effect. It is rapidly metabolized in vivo with formation of the azo-compound through dehydrogenation.
Preliminary Communications
Natulan (Procarbazine) Combined with Radiotherapy in Management of Inoperable Malignant Melanoma Brit. med. J., 1965 Brit. med. J., , 2, 1473 Brit. med. J., -1474 Natulan (N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride) (procarbazine) is a benzyl-methyl hydrazine derivative with cytotoxic effect. It is rapidly metabolized in vivo with formation of the azo-compound through dehydrogenation.
The mechanism by which the cytotoxic effect is exerted has been claimed to be due to the formation of 0 and OH radicals. Berneis, Kofler, Bollag, Kaiser, and Langemann (1963) , in their in titro studies with Natulan under aerobic conditions, noticed a decrease in the viscosity of aqueous deoxyribonucleic acid solutions and explained this phenomenon by the formation of hydrogen peroxide by autoxidation. They pointed out that if Natulan is added immediately after irradiation of deoxyribonucleic acid the radiation effect is potentiated. It therefore seemed desirable to study the combined action of Natulan and ionizing radiation in patients with malignant tumours resistant to radiation therapy. Good results were obtained with this combination in treating malignant mesothelioma (Falkson and Jacobs, 1964; Falkson, de Villiers, and Falkson, 1965) . Todd (1965) reported improvement in two out of six cases of melanomatosis treated with Natulan. We have observed objective improvement in six out of ten cases of inoperable malignant melanoma treated with combined Natulan and radiotherapy (see Table) . Five days before the start of Natulan a pericardial parasynthesis was done and 1,000 ml. of fluid was removed. Two days after the start of Natulan another 1,000 ml. of fluid was removed, followed 13 days later by 1,500 ml., and in 133 days by 1,500 ml. She improved sufficiently to walk about and go on holiday. The remission lasted for three months. Tle patient died 151 days after the beginning of treatment.
CASE 3
A 51-year-old woman had a history of local excision of a malignant melanoma from the right shoulder, which resulted in a symptom-free period of eight months. The lesion then recurred and was removed by broad excision; she was now readmitted with abdominal distension. The ascites was repeatedly tapped and bloody Preliminary Communications C .ORNAL fluid was removed. The duration of the disease from the start of the first lesion was 14 months. She died 23 days after Natulan was begun.
CASE 4
A man aged 57 was admitted for the removal of a polypoid protrusion from the nasal sinus. The histological diagnosis was malignant melanoma. He had had the polyp for five months. His general condition was good and he was able to carry on normal activities. Treatment with Natulan and telecobalt resulted in complete disappearance of measurable lesions, and he continued in remission 10 months after the start of treatment. He is now on maintenance therapy with Natulan.
CASE 5
A 67-year-old woman presented with multiple skin metastases on the right side of the face, as well as right-sided facial paralysis. The duration of the disease was 16 months. The previous treatment consisted of surgery (which resulted in three months' remission), intra-arterial triethylene-glycol diglycidyl ether, radiotherapy, and cyclophosphamide, none of which brought any favourable response.
At this stage she was unable to work, but was living at home and supplying most of her personal needs.
The lesions, which had grown despite previous radiotherapy, responded well to combined radiotherapy and Natulan. When a new lesion appeared on the neck four months after treatment with Natulan was started, it also responded to radiotherapy. Four months later pulmonary metastases developed and grew rapidly. She died 10 months after the start of Natulan. Her remission had lasted for seven months.
CASE 6
A 32-year-old man who had had local surgery to the foot, plus block-dissection of the inguinal lymph node four years previously, was admitted with a recurrence of lesions on the foot as well as bilateral lung metastases. He was unable to work, but was living at home and dealing with most of his personal needs. The lesions have remained unchanged for nine months since the start of treatment with Natulan.
CASE 7
In this 40-year-old woman the following findings were made at the start of treatment with Natulan. A mass, 4 by 3 cm., in the right breast, and lymphadenopathy in the right anterior axilla: the history dated back four years. She had previously had local excision of a malignant melanoma from the medial aspect of the right lower leg, followed by removal of the inguinal glands. She was free of symptoms for more than a year after surgery. When the lesion recurred in the right inguinal area it was removed surgically, followed by post-operative radiotherapy. This again resulted in an asymptomatic period for more than a year. Three weeks before the start of Natulan a metastatic lesion was removed from the right intercostal space.
After three weeks of treatment with Natulan and radiotherapy the mass had disappeared. The patient has been in complete remission for four months and is still taking a maintenance dosage of Natulan.
CASE 8
A 74-year-old woman had had a broad local excision of a malignant melanoma in the left scapular region two years previously. She was readmitted with massive enlargement of lymph nodes in the left axilla, the left supraclavicular area, and mediastinum. She was unable to care for personal needs and complained of severe pain.
Treatment resulted in rapid decrease in size of all measurable lesions. The lesions became more than 60% smaller, then generalized metastases developed and the patient died four months after the start of Natulan. Her remission had lasted for two months.
CASE 9
A 58-year-old woman was admitted with metastases in the skin of the upper medial thigh, below the scar of a block-dissection. She complained of pain in the whole of the left leg, was unable to work, but was living at home and caring for most of her personal needs. The previous treatment was surgery on three occasionsfirst, excision of a lesion from the medial side of the left ankle, resulting in a symptomatic period of eight months; secondly, a blockdissection of the left groin, which again resulted in eight months' remission ; the third surgical procedure (resection of a lesion from the left calf) had no favourable result. The lesions improved after Natulan and radiotherapy, but new lesions continued to appear on the left leg.
CASE 10
A 77-year-old woman had enucleation of the right eye for a malignant melanoma; she remained asymptomatic for more than a year. When lesions recurred exenteration of the right eye was performed.
When admitted for Natulan treatment she was bedridden, and severely ill with a paraplegia as a result of medullary metastases. She also had mediastinal metastases and a bedsore. She died one month after the start of treatment.
COMMENT
We feel that these results support the contention that Natulan (procarbazine) can sensitize tumour tissue to the damaging effects of ionizing radiations. We believe the response as well as the quality and duration of improvement to be significant, and feel that further investigations in the treatment of malignant melanoma with combined Natulan and radiotherapy are warranted.
